Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Joint Diseases × upadacitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Musculoskeletal Diseases 1 Joint Diseases 1 Arthritis, Rheumatoid 1 Arthritis 1

Interventions

upadacitinib 1 Surveys and Questionnaires 1 Sodium Chloride 1 Radiotherapy 1 Injections, Intra-Articular 1 Curcumin 1 Arthroplasty, Replacement, Shoulder 1 Arthroplasty, Replacement, Elbow 1 Anastrozole 1 Adrenal Cortex Hormones 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01960855 2021-08-24

A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy

AbbVie

Phase 2 Completed

276 enrolled 14 charts

Arthritis, Arthritis, Rheumatoid, Joint Diseases, Musculoskeletal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡